Stuart Linas, MD

Professional Titles

• Chief of Nephrology, Department of Medicine

Recognitions

• Top Doctor in Denver, 5280 Magazine (2011)
  Voted a 5280 best doctor by my peers in response to the question, "Which physician would you trust to treat you and your family?"

Publications

• Kelleher C and Linas SL. The patient with hypokalemia or hyperkalemia. In Manual of Nephrology, 6th edition RW Schrier editor, Lippincott,
• 30. Kelleher CE and Linas SL. Hypertensive Emergencies. Clicnical Critical Care Medicine. Edited by Albert RK, Sluttsky A, Ranieri M, Takala J, Torres A; Mosby Elsevevier
• Bristow MR, Linas SL, Port JD. Drugs in the Treatment of Heart Failure Braunwald’s heart disease. Ed by DP Zipes, p Libby, RO Bonow, E Braunwald 7th edition. Elsevier Saunders 569-602 2005
• 26. Chonchol M and Linas SL. Diagnosis and Management of Ischemic Nephropathy. Clinical J. Am. Society of Nephrology 1 172-181, 2006
• Proctor G, linas SL pseudohypoaldosteronism AJKD in press
• 76 Hanratty R, Chonchol M, Miriam Dickinson L, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranak EP. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrology Dialysis and Transplantation 25 810-807 2010
• Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV, Arterburn S, Sager P and Weber M. Divergent results using clinic and ambulatory blood pressures: Report of a Darusentan-resistant hypertension trial. Hypertension 56, 824-830, 2010.
• 78 Lesser CS, Lucey CR, Egener B, Braddock CH, Linas SL, Levinson W. A behavioral and Systems View of Professionalism. JAMA 304 2732-2737 2010.
• 31. Furgeson S.B. and Linas S.L. Mechanism of Type I and Type II Pseudohypoaldosteronism. JASN 21 1842-1845 2010
• Moore R. and Linas S.L. Role of Endothelin antagonists in treating hypertension. Current Opinions in Nephrology and Hypertension 19 432-436 2010.
• . Black HR, Bakris GL, Weber MA, Weiss R, El Shahawy M Marple R, Tannoury MD, Gerber M, Wiens BL, Linas SL, Roden R. Darusentan dose ranging trial for the treatment of resistant hypertension. Submitted

Practice Locations

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation

• University of Colorado Hospital
• Denver Health Medical Center

Specialty Information

Specialties

• Internal Medicine, Board Certification
• Nephrology, Board Certification

Conditions & Treatments

• Kidneys and Urinary System - Kidney Disease
• Kidneys and Urinary System